International Stem Cell CORP cotiza a 0.28 USD y tiene una capitalización bursátil de $2M. En los últimos 12 meses ha facturado $10M con un margen de flujo de caja libre del -0.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC-hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Par…
| Periodo | 2014-11 | 2014-08 | 2012-11 | 2012-08 |
|---|---|---|---|---|
| Real | $-1.50 | $-4.50 | $-3.00 | $-4.50 |
| Estimado | $-1.50 | $-1.50 | $-4.50 | $-4.50 |
| Sorpresa | +0.0% | -200.0% | +33.3% | +0.0% |
| Métrica | ISCO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 55.7% | 57.0% | -1.4% |
| Operating Margin | -2.9% | -38.6% | +35.7% |
| Net Margin | -4.6% | -33.6% | +29.0% |
| FCF Margin | -0.4% | -13.9% | +13.5% |
| ROE | — | -40.4% | — |
| ROA | -8.7% | -32.0% | +23.3% |
| Current Ratio | 0.74 | 2.84 | -2.10 |
| Debt / Equity | — | 0.28 | — |